This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MALE_GENITAL_EXALLC for full statistics.
malignant neoplasm of male genital organs
C3_MALE_GENITAL
male reproductive organ cancer: A reproductive organ cancer that is manifested in the male genital system. This includes organs such as the penis and scrotum.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
20377 |
6. Filter based on genotype QC (FinnGen only) |
20377 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
Similar endpoints
↥List of similar endpoints to
malignant neoplasm of male genital organs
based on the number of shared cases.
Similar with more cases:
- malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 20377 | - | 20377 |
| Unadjusted period prevalence (%) | 8.98 | - | 8.98 |
| Median age at first event (years) | 68.93 | - | 68.93 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 11915
- Matched controls
- 83988
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
13.5
323.3
632
346
116
Kela drug reimbursment
Prostate cancer
+∞
323.0
5838
*
WF002
NOMESCO Finland
Radical radiotherapy
19.1
323.0
2410
1097
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
353.5
323.0
2673
68
TKE00
NOMESCO Finland
Needle biopsy of prostate
13.9
323.0
2285
1409
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
31.6
323.0
1033
251
NK6AN
NOMESCO Finland
Total body bone isotope imaging
73.2
323.0
1371
149
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
36.3
323.0
4743
1501
G04BE03
ATC
sildenafil; oral
36.3
323.0
823
171
N40
ICD-10 Finland
Hyperplasia of prostate
2.2
323.0
5235
21891
Y77
ICPC
Malignant neoplasm prostate
275.7
323.0
2141
67
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
323.0
438
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
323.0
3341
9768
KEB00
NOMESCO Finland
Biopsy of prostate
16.8
323.0
652
289
L02BB03
ATC
bicalutamide; oral
2526.4
323.0
2383
8
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
14.4
323.0
772
403
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
6.0
323.0
4702
8266
UKC02
NOMESCO Finland
Cystoscopy
2.7
323.0
3187
10127
ZXC96
NOMESCO Finland
Robot assisted procedure
53.3
323.0
1815
282
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
177.2
323.0
1340
60
KC1GB
NOMESCO Finland
Cystography with X-ray
54.2
323.0
695
96
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
14.5
323.0
1353
734
J01EA01
ATC
trimethoprim; systemic
3.8
323.0
2565
5710
L02AE02
ATC
leuprorelin; implant, parenteral
7247.5
323.0
3646
5
L02AE03
ATC
goserelin; implant
732.1
323.0
593
6
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
1103.2
323.0
863
6
JN4BD
NOMESCO Finland
Extensive body CT
3.5
323.0
2013
4587
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
8.9
323.0
1054
908
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
16.8
323.0
3393
1939
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
4.4
323.0
2833
5587
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
31.5
323.0
689
163
XJH00
NOMESCO Finland
Transanal ultrasonography
5.6
323.0
2277
3394
G03HA01
ATC
cyproterone; systemic
121.2
323.0
463
28
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
201.5
323.0
1044
40
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
80.1
323.0
1271
125
L02BX02
ATC
degarelix; parenteral
+∞
323.0
821
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
4503599627370496.0
323.0
11136
27
XKD00
NOMESCO Finland
Uroflowmetry
7.0
323.0
6158
11065
KFC10
NOMESCO Finland
Bilateral orchiectomy
288.0
323.0
397
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
323.0
4289
13729
KE1BG
NOMESCO Finland
MRI of prostate
26.2
323.0
510
143
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
59.0
323.0
679
86
C61
ICD-10 Finland
Malignant neoplasm of prostate
1575.3
323.0
11006
652
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
323.0
633
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
323.0
2291
3117
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
18.8
323.0
597
235
G04CA02
ATC
tamsulosin; oral
2.2
323.0
5473
23535
L02BB04
ATC
enzalutamide; oral
+∞
323.0
500
*
L02AE04
ATC
triptorelin; parenteral
3552.2
323.0
491
*
J01MA02
ATC
ciprofloxacin; systemic
2.2
312.9
5308
22768
L02BX03
ATC
abiraterone; oral
+∞
305.2
335
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
10.2
301.4
672
488
G04BE01
ATC
alprostadil; parenteral, urethral
7.6
301.2
797
781
M05BX04
ATC
denosumab; parenteral
9.3
288.2
674
535
KDE20
NOMESCO Finland
Removal of foreign body from urethra
21.2
276.0
458
158
ZX070
NOMESCO Finland
Intensity modified radiotherapy
10.2
259.3
579
420
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
14.7
256.4
483
240
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
217.3
254.5
299
10
WF090
NOMESCO Finland
Profylactic radiotherapy
178.2
249.0
296
12
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
10.8
248.0
537
366
KE1CG
NOMESCO Finland
Extensive MRI of prostate
32.1
247.0
367
83
KFC00
NOMESCO Finland
Unilateral orchiectomy
18.0
238.4
417
169
WF003
NOMESCO Finland
Adjuvant radiotherapy
7.7
236.2
621
598
TKE10
NOMESCO Finland
Puncture of prostate
80.6
236.1
301
27
ZX090
NOMESCO Finland
Other technic of radiotherapy
9.0
233.2
554
450
K62.7
ICD-10 Finland
Radiation proctitis
304.8
220.7
255
6
N39.3
ICD-10 Finland
Stress incontinence
23.2
216.3
349
109
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
42.1
215.8
303
52
JN4AD
NOMESCO Finland
Body CT examination
3.2
212.3
1337
3233
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
27.7
206.8
318
83
L01XX11
ATC
estramustine; systemic
+∞
200.9
221
*
3054
Kela drug reimbursment
NA
+∞
196.4
216
*
1523
Kela drug reimbursment
NA
+∞
196.4
216
*
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
395.7
193.1
221
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
192.8
3199
12909
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
62.8
192.3
253
29
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
90.8
190.9
240
19
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
12.4
187.5
379
222
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
15.2
183.1
340
162
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.1
180.8
650
945
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
35.0
177.2
258
53
B01AB05
ATC
enoxaparin; parenteral
1.9
177.0
3378
14293
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.5
173.7
695
1133
N02BE01
ATC
paracetamol; systemic, rectal
1.9
173.5
9149
53784
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
169.0
186
*
L02BB01
ATC
flutamide; oral
1288.8
167.7
187
*
OAB42
NOMESCO Finland
Guidance related to known health problem
41.7
153.0
215
37
KED22
NOMESCO Finland
Transurethral resection of prostate
2.5
152.9
1380
4136
R31
ICD-10 Finland
Unspecified haematuria
2.2
147.2
1792
6236
WZC30
NOMESCO Finland
Teaching
2.3
146.5
1651
5540
R33
ICD-10 Finland
Retention of urine
2.3
145.8
1566
5132
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
145.5
4456
21708
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
5.7
144.0
468
602
G04BE30
ATC
drugs used in erectile dysfunction - combinations
151.0
140.6
169
8
G04BD12
ATC
mirabegron; oral
2.6
137.2
1132
3214
Y06
ICPC
Prostate symptom/complaint
3.6
137.1
709
1456
ZX080
NOMESCO Finland
Image guided radiotherapy
9.7
135.3
307
228
ZX112
NOMESCO Finland
Subcutaneous
6.6
131.8
379
414
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
1040.6
128.6
144
*
7512
FHL
Orchidectomy (bilateral)
1032.5
127.7
143
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
81.6
125.9
160
14
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
40.8
125.6
177
31
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
331.6
121.6
140
*
H02AB02
ATC
dexamethasone; systemic
2.4
120.2
1137
3469
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
113.0
1904
7504
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
57.9
109.9
146
18
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
108.9
120
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
106.9
4870
25718
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
288.3
105.4
122
*
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
17.4
105.3
185
76
U04
ICPC
Incontinence urine
3.9
104.9
481
888
TQW40
NOMESCO Finland
Remowal of suture of skin
2.6
104.6
851
2379
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.7
104.5
514
1009
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
8.0
100.2
253
227
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
14.4
98.1
185
92
G04CA01
ATC
alfuzosin; oral
1.7
97.8
2426
10827
G04BD08
ATC
solifenacin; oral
2.7
95.5
730
1964
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
60.0
89.4
118
14
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
88.3
1064
3627
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
18.1
86.7
150
59
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
6.6
82.7
237
258
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
223.4
81.2
95
*
8000/3-C61.9
ICD-O-3
Neoplasm, malignant of prostate gland
+∞
80.7
89
*
Z51.0
ICD-10 Finland
Radiotherapy session
7.1
80.4
218
219
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
39.8
79.4
112
20
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
33.8
78.2
114
24
ZXC20
NOMESCO Finland
Use of chemical agents
4.6
77.9
298
461
L03AA13
ATC
pegfilgrastim; parenteral
4.1
77.4
333
579
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
304.0
74.5
86
*
WX402
NOMESCO Finland
General anaesthesia
1.8
73.8
1573
6629
2BX02
NOMESCO Finland
NA
+∞
72.5
80
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
35.2
72.0
104
21
KDW96
NOMESCO Finland
Other operations on urethra
41.8
71.6
100
17
G04BE09
ATC
vardenafil; oral
66.1
71.5
93
10
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
9.1
71.3
166
130
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
149.0
70.0
84
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
282.5
69.1
80
*
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
5.0
68.8
243
345
N02AA05
ATC
oxycodone; systemic
1.7
67.3
1673
7373
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.6
67.3
562
1587
HB000
NOMESCO Finland
Profylactic radiotherapy of mammary gland
+∞
67.1
74
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.6
65.9
527
1452
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
4.1
64.3
277
483
KDG43
NOMESCO Finland
Transobturatorial sling urethrocystopexy
179.8
64.2
76
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
21.7
63.9
104
34
KD1GB
NOMESCO Finland
Uretrocystogpaphy with X-ray
15.9
63.2
114
51
R74.9
ICD-10 Finland
Abnormal level of unspecified serum enzyme
8.6
62.6
150
124
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
62.3
3522
18852
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
61.7
68
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
91.0
61.6
77
6
ZX050
NOMESCO Finland
Stereotactic radiotherapy
7.7
60.7
156
145
JN4CD
NOMESCO Finland
Very extensive body CT
2.5
60.5
520
1491
L03AA14
ATC
lipegfilgrastim; parenteral
5.8
60.1
188
231
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.5
59.6
307
626
WF004
NOMESCO Finland
Palliative radiotherapy
3.6
59.4
300
602
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
58.6
1546
6905
XKG00
NOMESCO Finland
Artificial induction of erection
22.5
57.2
92
29
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.6
57.1
475
1336
XX7FT
NOMESCO Finland
Radioyttrium therapy with connected antibody
232.4
56.6
66
*
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
158.2
56.2
67
*
U77
ICPC
Malignant neopl urinary tract other
49.0
56.1
76
11
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.6
55.9
278
551
N30.4
ICD-10 Finland
Irradiation cystitis
153.5
54.4
65
*
J01MA12
ATC
levofloxacin; systemic
1.5
54.4
2148
10603
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
53.5
59
*
L02AE01
ATC
buserelin; implant, nasal, parenteral
+∞
53.5
59
*
TKC22
NOMESCO Finland
Catheterisation instruction
3.0
52.0
340
826
A04AA02
ATC
granisetron; systemic, transdermal
2.2
51.8
564
1825
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
20.8
51.7
85
29
R86.1
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of hormones
9.6
51.2
115
85
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
66.8
51.0
66
7
XKD03
NOMESCO Finland
Urethral pressure profilometry
4.8
50.8
188
282
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
402.7
50.0
57
*
Y78
ICPC
Malign neopl male genital other
141.6
50.0
60
*
R86.9
ICD-10 Finland
Abnormal findings in specimens from male genital organs, unspecified abnormal finding
8.3
48.8
119
102
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
4.7
48.7
182
276
Z51.5
ICD-10 Finland
Palliative care
2.0
47.6
690
2522
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
8.2
47.4
116
100
Z3231
NOMESCO Finland
Registered nurse
1.4
47.0
2672
14158
G04BE08
ATC
tadalafil; oral
25.2
45.7
71
20
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
21.0
45.3
74
25
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.8
45.1
166
248
J01MA01
ATC
ofloxacin; systemic
1.7
45.0
1036
4430
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
43.7
538
1836
WX320
NOMESCO Finland
Spinalanesthesy
1.5
43.6
2034
10349
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
10.7
43.4
92
61
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.5
42.8
380
1110
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
120.3
42.0
51
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
26.2
41.1
63
17
XX1AD
NOMESCO Finland
Other CT-examination
8.3
41.1
100
86
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
40.8
45
*
A79
ICPC
Malignancy NOS
4.4
40.8
163
266
1CD02
NOMESCO Finland
NA
21.2
40.6
66
22
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
6.1
40.3
121
142
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
25.8
40.3
62
17
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
40.0
4486
26419
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
39.9
1000
4374
KDK10
NOMESCO Finland
Implantation of artificial urinary sphincter around bulbar urethra
47.8
39.9
54
8
WF099
NOMESCO Finland
Other radiotherapy
8.3
39.6
96
82
D07.5
ICD-10 Finland
Carcinoma in situ: Prostate
70.8
39.1
50
5
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
6.8
39.0
107
111
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
10.7
37.9
80
53
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
8.3
37.5
91
78
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
36.3
1207
5679
KE003
NOMESCO Finland
Adjuvant radiotherapy of prostata and seminal vesicles
+∞
36.2
40
*
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
+∞
36.2
40
*
N99.1
ICD-10 Finland
Postprocedural urethral stricture
5.1
36.0
123
170
NK6SN
NOMESCO Finland
Bone SPECT
36.1
35.8
51
10
KCC10
NOMESCO Finland
Cystoprostatectomy
5.0
35.7
125
178
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
48.6
35.6
48
7
L02AA02
ATC
polyestradiol phosphate; parenteral
+∞
35.3
39
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
35.3
39
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.3
35.1
359
1127
N30.0
ICD-10 Finland
Acute cystitis
1.8
33.7
630
2519
B01AB10
ATC
tinzaparin; parenteral
1.8
33.5
600
2362
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
33.3
2740
15311
KE1DM
NOMESCO Finland
Very extensive MRI of prostate (more than 1.5 T)
45.4
33.0
45
7
G04BD07
ATC
tolterodine; oral
2.1
32.9
413
1424
OAB77
NOMESCO Finland
Discussion on exercise habits and instruction concerning use of sports and fitness services
+∞
32.6
36
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
8.9
32.3
75
60
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
50.7
32.2
43
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
31.8
975
4491
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
31.7
35
*
8010/3-C61.9
ICD-O-3
Carcinoma, NOS, of prostate gland
+∞
31.7
35
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
58.0
31.3
41
5
7455
FHL
Retropubic total prostatectomy
42.4
30.5
42
7
J01CA08
ATC
pivmecillinam; oral
1.7
30.4
652
2723
N35.9
ICD-10 Finland
Urethral stricture, unspecified
2.8
30.4
207
520
R39.1
ICD-10 Finland
Other difficulties with micturition
2.1
30.4
392
1367
WX110
NOMESCO Finland
Local anesthesy
1.3
30.1
5857
36540
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
29.9
33
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
29.9
33
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
7.0
29.5
79
80
A28
ICPC
Limited function/disability NOS
1.5
29.2
1301
6512
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
29.0
3441
20171
5BX04
NOMESCO Finland
NA
36.2
28.9
41
8
18699
ICD-8 Finland
Malignant neoplasm of testis
84.8
28.8
36
*
7461
FHL
Needle biopsy in the operating room
4.3
28.3
113
186
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.2
28.1
305
987
KDV10
NOMESCO Finland
Internal urethrotomy
2.7
27.9
206
544
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
2.8
27.7
189
474
KCD02
NOMESCO Finland
Transurethral resection of bladder
2.0
27.1
375
1344
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
27.0
668
2904
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
26.9
6225
39385
WVA20
NOMESCO Finland
Medicine administration
2.5
26.4
222
631
XX1XQ
NOMESCO Finland
Other SPECT-CT
113.0
26.4
32
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.8
26.2
457
1787
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
26.1
2225
12428
WVA30
SPAT
NA
2.3
26.0
252
773
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
25.4
28
*
A07EA02
ATC
hydrocortisone; rectal
2.5
25.0
213
610
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.4
25.0
1149
5776
KE1AE
NOMESCO Finland
Percutaneous utlrasound examination fo prostata
5.4
24.8
80
105
UJF32
NOMESCO Finland
Coloscopy
1.3
24.5
2265
12786
ZXE00
NOMESCO Finland
One hour or less
1.3
24.4
3411
20311
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
198.5
24.0
28
*
XKC03
NOMESCO Finland
Water cystometry
2.5
23.9
209
607
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
2.0
23.8
312
1095
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
8.6
23.6
55
45
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
7.9
23.6
58
52
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
23.6
26
*
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
23.2
713
3281
B02AA02
ATC
tranexamic acid; systemic
1.7
23.1
550
2365
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
191.2
23.1
27
*
C05AA08
ATC
fluocortolone; rectal, topical
1.4
23.0
1189
6106
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
11.1
23.0
47
30
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
22.9
1036
5190
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
22.6
25
*
KEC10
NOMESCO Finland
Perineal radical prostatectomy
+∞
22.6
25
*
G04CB02
ATC
dutasteride; oral
1.5
22.6
988
4916
SPAT1254
SPAT
Administration of medicine
1.4
22.5
1190
6135
J01MA06
ATC
norfloxacin; oral
1.5
22.5
828
3969
U06
ICPC
Haematuria
2.2
22.1
249
822
OAB75
NOMESCO Finland
Nutritional guidance related to maintaining health
36.5
22.1
31
6
KA3EB
NOMESCO Finland
Antegrade pyelography
4.5
22.0
84
133
D40.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Male genital organ, unspecified
8.1
22.0
53
46
SPAT1167
SPAT
Insertion of urinary catheter
1.9
22.0
364
1398
J01DB01
ATC
cefalexin; oral
1.2
22.0
7834
51305
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.3
22.0
1793
9926
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
21.9
721
3370
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.9
21.3
141
350
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
2.1
21.2
250
842
R4110
NOMESCO Finland
Physiotherapy
1.3
21.0
2285
13145
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
27.4
20.7
31
8
G04BD11
ATC
fesoterodine; oral
2.2
20.6
217
694
C62
ICD-10 Finland
Malignant neoplasm of testis
169.4
20.4
24
*
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
4.2
20.4
83
141
ZXA10
NOMESCO Finland
Bilateral
1.3
20.4
1395
7512
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
7.1
20.2
53
53
JGA28
NOMESCO Finland
Endoscopic contact coagulation in rectum
26.5
19.9
30
8
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
19.9
22
*
KE099
NOMESCO Finland
Other radiotherapy of prostata and seminal vesicles
+∞
19.9
22
*
U76
ICPC
Malignant neoplasm of bladder
7.1
19.9
52
52
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.6
19.6
237
2948
KDV20
NOMESCO Finland
Submucous urethral injection
21.9
19.6
31
10
C61, D400
ICD-10 Finland
NA
162.4
19.5
23
*
SPAT1262
SPAT
Handing over of treatment supplies
1.3
19.5
1820
10254
SPAT1053
SPAT
Memory test
1.4
19.4
1172
6178
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
84.7
19.3
24
*
KGC00
NOMESCO Finland
Partial amputation of penis
45.8
19.3
26
*
A04AA01
ATC
ondansetron; systemic, rectal
1.7
19.2
463
1999
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
2.0
19.2
246
860
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
19.0
21
*
-50
ICPC
Medication/prescr/renewal
1.8
18.7
339
1345
Y50
ICPC
Male Genital, Medication/prescr/renewal
8.7
18.7
43
35
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
18.5
931
4752
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
18.4
849
4267
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
14.6
18.3
33
16
WB211
NOMESCO Finland
Neoadjuvant hormone therapy of malignancy
+∞
18.1
20
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
17.9
1649
9261
A06AD11
ATC
lactulose; oral
1.3
17.8
1465
8099
WW500
NOMESCO Finland
Blood transfusion
1.7
17.8
355
1451
Z02.4
ICD-10 Finland
Examination for driving licence
1.2
17.6
2526
14978
A55
ICPC
General and Unspecified, Local injection/infiltration
3.1
17.6
102
233
TQX05
NOMESCO Finland
Skin puncture, unspecified location
7.8
17.6
43
39
U08
ICPC
Urinary retention
2.0
17.5
222
771
U29
ICPC
Urinary symptom/complaint other
2.1
17.4
197
654
S18
ICPC
Laceration/cut
1.2
17.3
3697
22838
SPAT1304
SPAT
Counselling and guidance related to ageing
1.6
17.2
480
2156
A02BC02
ATC
pantoprazole; systemic
1.2
17.0
5919
38191
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
2.3
16.9
159
484
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.3
16.9
1493
8332
UKD02
NOMESCO Finland
Urethroscopy
3.9
16.8
74
136
SPAT1325
SPAT
Vaccination
1.2
16.7
2626
15710
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
16.7
1898
10946
U05
ICPC
Urination problems other
1.7
16.7
375
1589
6000A
ICD-9 Finland
Hyperplasia of prostate[HYPERPLASIA PROSTATAE]
1.7
16.4
339
1401
SPAT1263
SPAT
Sampling
1.2
16.4
3333
20468
KE2KT
NOMESCO Finland
Marker implantation in prostate under radiological guidance
+∞
16.3
18
*
JGA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in rectum
28.2
16.3
24
6
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
16.3
964
5063
U13
ICPC
Bladder symptom/complaint other
2.3
16.2
162
510
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
3.2
16.1
87
190
JN2BM
NOMESCO Finland
Lower part of abdomen MRI examination with Tesla magnet
38.8
16.0
22
*
KDK40
NOMESCO Finland
Removal of artificial urethral sphincter
134.1
16.0
19
*
TKD00
NOMESCO Finland
Dilatation of urethra
3.3
15.9
85
184
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
15.9
20
620
ZX100
NOMESCO Finland
Oral
2.4
15.8
137
399
H91.1
ICD-10 Finland
Presbycusis
1.5
15.7
491
2268
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.3
15.6
1341
7455
KEW98
NOMESCO Finland
Other transluminal endoscopic operation on prostate
+∞
15.4
17
*
KE2JT
NOMESCO Finland
Demanding radiation source placement in prostate under ultrasound guidance
+∞
15.4
17
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
15.4
17
*
D29.1
ICD-10 Finland
Benign neoplasm: Prostate
3.4
15.3
77
159
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.3
15.3
1855
10771
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
15.2
8576
57370
7451
FHL
Transurethral adenoma removal
1.9
15.1
249
956
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
2.7
15.1
111
296
R86
ICD-10 Finland
Abnormal findings in specimens from male genital organs
8.6
14.8
34
28
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
14.8
270
1075
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
14.8
1338
7487
1530
FHL
Urethrocystoscopy
1.8
14.7
246
953
A98
ICPC
Health maint/preventive medicine
1.2
14.7
9199
61990
KE2AT
NOMESCO Finland
Cytologoy of prostata with ultrasound guidance
13.6
14.7
27
14
SPAT1088
SPAT
Blood transfusion
3.8
14.6
64
118
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.8
14.6
250
976
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
14.5
1639
9427
C08CA01
ATC
amlodipine; oral
1.2
14.5
3539
22040
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
14.5
16
*
L01AA04
ATC
NA
+∞
14.5
16
*
Z2221
NOMESCO Finland
Medical doctor
1.2
14.4
2115
12534
L57.0
ICD-10 Finland
Actinic keratosis
1.4
14.4
723
3687
N48.4
ICD-10 Finland
Impotence of organic origin
1.7
14.4
283
1155
R60.0
ICD-10 Finland
Localized oedema
1.4
14.1
799
4162
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.2
13.7
1753
10226
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
3.4
13.7
68
140
U28
ICPC
Limited function/disability (U)
2.5
13.6
108
301
SPAT1153
SPAT
Removal of sutures
1.2
13.6
2722
16631
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
13.6
15
*
A07DA03
ATC
loperamide; oral
1.6
13.5
323
1395
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
1.8
13.5
233
912
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
4.6
13.4
48
73
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
1.9
13.4
208
784
A06AH03
ATC
naloxegol; oral
2.5
13.4
110
313
N21.0
ICD-10 Finland
Calculus in bladder
2.2
13.4
137
435
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
6.9
13.4
35
36
1CD04
NOMESCO Finland
NA
112.9
13.3
16
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
13.3
1089
6007
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
13.3
1361
7732
U99
ICPC
Urinary disease other
3.2
13.1
73
162
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
1.7
13.0
278
1165
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
2.2
13.0
142
467
H84
ICPC
Presbyacusis
1.8
13.0
229
904
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.6
13.0
386
1764
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
14.8
13.0
23
11
WW200
SPAT
NA
0.7
13.0
375
3848
SPAT1312
SPAT
General health counselling
1.2
12.9
2253
13579
KGB00
NOMESCO Finland
Biopsy of penis
4.9
12.9
44
64
JN5AN
NOMESCO Finland
Total body isotope imaging
26.8
12.9
19
5
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
12.8
2327
18888
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.5
12.8
508
2478
M05BA02
ATC
clodronic acid; systemic
3.9
12.7
55
101
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
12.7
14
*
SPAT1301
SPAT
No procedures
1.2
12.7
2459
14966
U07
ICPC
Urine symptom/complaint other
1.6
12.5
344
1546
KGD05
NOMESCO Finland
Partial excision of body of penis
56.5
12.4
16
*
KA1FN
NOMESCO Finland
Isotope renography
3.1
12.4
72
167
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
6.0
12.3
35
41
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
12.2
461
2224
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
7.1
12.1
31
31
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.3
12.1
31
666
KA1AE
NOMESCO Finland
Kidney ultrasound examination
1.7
12.1
232
942
-44
ICPC
Preventive immunization/medic
1.4
12.1
535
2670
G04BD09
ATC
trospium; oral
2.2
12.0
130
426
-55
ICPC
Local injection/infiltration
3.1
12.0
69
159
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
4.5
11.9
43
67
Y77
ICD-10 Finland
Ophthalmic devices associated with adverse incidents
+∞
11.8
13
*
JR1AS
NOMESCO Finland
Restricted PET-MRI of receptors/transporters in body
+∞
11.8
13
*
WX704
NOMESCO Finland
Intubation
1.4
11.8
510
2533
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.4
11.6
55
913
KGH10
NOMESCO Finland
Operation for phimosis
1.6
11.6
323
1455
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
1.5
11.4
381
1795
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
1.9
11.4
160
586
Z51.88
ICD-10 Finland
Other specified medical care
2.0
11.3
147
522
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
3.3
11.3
58
124
R50.9
ICD-10 Finland
Fever, unspecified
1.3
11.3
1163
6609
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
2.0
11.2
142
497
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.3
11.2
703
3728
NF3AA
NOMESCO Finland
Femur X-ray examination
2.0
11.2
150
538
U50
ICPC
Urological, Medication/prescr/renewal
18.1
11.0
18
7
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
5.8
11.0
32
39
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
10.9
219
903
N06AX11
ATC
mirtazapine; oral
1.2
10.9
2273
13901
8041/3-C61.9
ICD-O-3
Small cell carcinoma, NOS, of prostate gland
+∞
10.9
12
*
2AE02
NOMESCO Finland
NA
+∞
10.9
12
*
N05AC02
ATC
thioridazine; oral
0.4
10.8
33
654
N04AA02
ATC
biperiden; systemic
0.4
10.8
40
733
N05AA02
ATC
levomepromazine; systemic
0.6
10.7
174
2006
N02AA01
ATC
morphine; systemic, rectal
2.0
10.7
147
534
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.4
10.7
490
2460
N41.0
ICD-10 Finland
Acute prostatitis
1.6
10.7
269
1182
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
6.6
10.6
28
30
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.6
10.5
277
1232
N05CF01
ATC
zopiclone; oral
1.2
10.4
2802
17499
N35.8
ICD-10 Finland
Other urethral stricture
3.3
10.4
54
117
N42.8
ICD-10 Finland
Other specified disorders of prostate
3.3
10.3
53
114
JN2BD
NOMESCO Finland
Extensive CT exmaniation of lower part of abdomen
4.5
10.3
37
58
H81
ICPC
Excessive ear wax
1.2
10.2
1366
7994
XKD11
NOMESCO Finland
NA
6.6
10.2
27
29
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
0.6
10.2
207
2270
TKE05
NOMESCO Finland
Aspiration cytology of prostate
14.1
10.1
18
9
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
5.8
10.1
29
35
R53
ICD-10 Finland
Malaise and fatigue
1.2
10.1
1407
8273
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
3.7
10.1
44
83
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.4
10.1
419
2067
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.6
10.0
121
1499
A10AA01
ATC
NA
0.5
10.0
58
893
WC225
NOMESCO Finland
Demanding therapy of local tumor recidive with hormone
+∞
10.0
11
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
10.0
11
*
H25.8
ICD-10 Finland
Other senile cataract
1.3
9.9
815
4496
P72
ICPC
Schizophrenia
0.3
9.9
23
515
G04AC01
ATC
NA
2.2
9.9
103
334
U02
ICPC
Urinary frequency/urgency
1.4
9.9
469
2375
ZX110
NOMESCO Finland
Intracutaneous
4.9
9.8
33
48
WX290
NOMESCO Finland
Other blockade of nerve
1.2
9.7
3006
18957
A10AA02
ATC
NA
0.6
9.7
122
1498
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.7
9.7
386
3745
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.4
9.7
43
729
D64.8
ICD-10 Finland
Other specified anaemias
2.0
9.7
128
459
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1.8
9.6
170
677
KED76
NOMESCO Finland
TUVP
2.2
9.6
98
315
WX872
NOMESCO Finland
Intensive care
0.7
9.5
284
2893
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.2
9.5
1083
6226
M05BA08
ATC
zoledronic acid; parenteral
16.1
9.5
16
7
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.4
9.4
490
2524
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
9.4
2051
12580
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
3.3
9.3
48
104
SPAT1168
SPAT
Catheterisation training
2.6
9.3
67
181
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
9.3
793
4400
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
4.3
9.3
35
58
N30
ICD-10 Finland
Cystitis
1.7
9.2
184
758
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.1
9.2
105
353
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.4
9.2
453
2308
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
1.5
9.1
297
1391
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.3
9.1
962
5480
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.1
9.1
3067
19445
H02AB06
ATC
prednisolone; systemic
1.1
9.1
4121
26660
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
5.3
9.1
28
37
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.7
9.1
426
4033
XX7LT
NOMESCO Finland
Lutetium-177-PSMA treatment
+∞
9.1
10
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
1.6
9.1
238
1060
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.5
9.0
56
846
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.2
9.0
1459
8700
C60.2
ICD-10 Finland
Malignant neoplasm: Body of penis
42.3
9.0
12
*
L03AA02
ATC
filgrastim; parenteral
1.7
9.0
197
837
18599
ICD-8 Finland
Malignant neoplasm of prostate
77.6
8.9
11
*
ZX137
NOMESCO Finland
To penis
77.6
8.9
11
*
ZX120
NOMESCO Finland
Intravenous
1.3
8.9
715
3935
N05AH02
ATC
clozapine; systemic
0.3
8.9
22
475
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.9
8.9
1891
15212
KWA00
NOMESCO Finland
Repair of wound dehiscence in urological surgery
7.1
8.8
22
22
SPAT1154
SPAT
Insertion or removal of subcutaneous medicine capsule
5.3
8.8
27
36
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
0.5
8.7
87
1133
KGD00
NOMESCO Finland
Partial excision of glans penis
15.1
8.7
15
7
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.3
8.7
80
246
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.3
8.7
548
2909
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
0.7
8.7
388
3698
A10BK03
ATC
empagliflozin; oral
0.7
8.7
400
3797
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
8.7
1860
11382
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
0.5
8.7
78
1045
N05AF05
ATC
zuclopenthixol; systemic
0.3
8.6
13
363
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.2
8.6
963
5525
188
Kela drug reimbursment
Psychosis requiring demanding treatment
0.2
8.6
7
279
C03CA01
ATC
furosemide; systemic
1.1
8.5
3038
19324
P20
ICPC
Memory disturbance
1.3
8.5
835
4720
SPAT1310
SPAT
Counselling related to known health issue
1.2
8.5
2320
14478
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.2
8.4
83
263
H26.4
ICD-10 Finland
After-cataract
1.3
8.4
547
2923
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
3.4
8.4
41
86
T89
ICPC
Diabetes insulin dependent
0.6
8.4
111
1339
G04BXXX
ATC
NA
28.2
8.4
12
*
B01AE07
ATC
dabigatran etexilate; oral
1.5
8.3
322
1567
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.9
8.3
1927
15414
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
1.6
8.2
232
1055
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
8.2
2481
15592
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
8.2
9
*
KE1AK
NOMESCO Finland
Spectroscopy of prostate
+∞
8.2
9
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
8.2
9
*
KE029
NOMESCO Finland
Radiotherapy of local recidive of tumor of prostata and seminal vesicles
+∞
8.2
9
*
KDE12
NOMESCO Finland
Urethroscopic extraction of calculus of urethra
18.3
8.1
13
5
C60.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of penis
70.5
8.1
10
*
5703
FHL
Removal of lymph nodes from the retroperitoneal space
7.1
8.1
20
20
S50
ICPC
Skin, Medication/prescr/renewal
2.6
8.1
61
169
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
1.9
8.0
121
457
D29.2
ICD-10 Finland
Benign neoplasm: Testis
5.0
8.0
26
37
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
8.0
2044
12678
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
1.7
8.0
159
658
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.6
8.0
58
158
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
3.8
8.0
34
64
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.2
7.9
1011
5883
NF1AA
NOMESCO Finland
Hip X-ray examination
1.3
7.9
601
3285
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.4
7.9
319
1568
B01AB04
ATC
dalteparin; parenteral
1.4
7.9
337
1674
H02
ICPC
Hearing complaint
1.2
7.8
856
4899
N05AH03
ATC
olanzapine; systemic
0.7
7.8
177
1898
U01
ICPC
Dysuria/painful urination
1.6
7.8
180
778
C10AA01
ATC
simvastatin; oral
1.1
7.7
4659
30591
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.1
7.7
2484
15681
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.4
7.7
345
1732
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
2.0
7.6
96
341
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.5
7.6
54
778
WX725
NOMESCO Finland
Noninvasive ventilation
1.4
7.6
333
1665
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.4
7.6
363
1844
L82
ICD-10 Finland
Seborrhoeic keratosis
1.2
7.6
999
5837
KED33
NOMESCO Finland
Transurethral incision of prostate
1.6
7.6
183
803
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.3
7.5
588
3224
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.4
7.5
396
2045
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
4.1
7.5
29
50
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.6
7.4
111
1301
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.1
7.4
2676
17009
R32
ICD-10 Finland
Unspecified urinary incontinence
1.9
7.4
110
414
N05AX12
ATC
aripiprazole; systemic
0.5
7.4
47
699
A04AD12
ATC
aprepitant; systemic
2.0
7.4
90
316
KC1AT
NOMESCO Finland
Puncture of urinary bladder with ultrasound guidance
3.8
7.4
31
58
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
1.9
7.3
108
407
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
5.7
7.3
21
26
DFF00
NOMESCO Finland
Pure tone audiometry
1.3
7.3
639
3560
N03AG01
ATC
valproic acid; systemic, rectal
0.7
7.3
206
2117
4194
NOMESCO Finland
NA
13.1
7.3
13
7
JR2PR
NOMESCO Finland
NA
+∞
7.2
8
*
YN2AS
NOMESCO Finland
NA
+∞
7.2
8
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
63.5
7.2
9
*
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
63.5
7.2
9
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
0.5
7.2
72
933
K59.0
ICD-10 Finland
Constipation
1.4
7.2
371
1912
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.3
7.2
438
2319
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
7.2
845
4877
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
1.8
7.1
110
422
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.4
7.1
320
1609
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
4.1
7.1
27
46
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.3
7.1
524
2854
KH1AD
NOMESCO Finland
CT of urinary organs
1.4
7.1
289
1427
D16
ICPC
Rectal bleeding
1.8
7.1
122
485
N05AF03
ATC
chlorprothixene; systemic
0.5
7.0
73
938
D70.82
ICD-10 Finland
Drug-induced neutropenia
1.9
7.0
103
387
KCJ00
NOMESCO Finland
Cystostomy
5.6
7.0
20
25
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
1.4
6.9
281
1385
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
11.5
6.9
13
8
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
2.4
6.9
55
160
Z43.5
ICD-10 Finland
Attention to cystostomy
2.2
6.9
65
205
N05AA01
ATC
chlorpromazine; systemic, rectal
0.4
6.8
30
505
L04AA06
ATC
mycophenolic acid; systemic
0.5
6.7
43
637
TJF80
NOMESCO Finland
Ostomy education
2.0
6.7
82
287
SPAT1211
SPAT
Application of soft bandage
1.3
6.7
583
3247
ZX136
NOMESCO Finland
Intravesicalis
2.1
6.7
74
251
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.5
6.7
222
1050
SPAT1249
SPAT
Treatment-related counselling outside office
1.1
6.7
2895
18605
KCH42
NOMESCO Finland
Transurethral incision or resection of bladder neck
3.0
6.7
38
90
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
5.6
6.6
19
24
H02AB07
ATC
prednisone; oral
1.2
6.6
1093
6533
H13
ICPC
Plugged feeling ear
1.2
6.6
1409
8617
R42
ICD-10 Finland
Dizziness and giddiness
1.2
6.5
1496
9192
JGA35
NOMESCO Finland
Other endoscopic haemostatic procedure in rectum
12.1
6.5
12
7
XA800
NOMESCO Finland
Neuropsychological investigation
0.7
6.5
142
1526
PJA12
NOMESCO Finland
Sentinel node biopsy
1.7
6.5
120
488
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.5
6.4
235
1135
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
4.8
6.4
21
31
M01AX05
ATC
glucosamine; oral
1.2
6.4
1293
7864
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
2.1
6.4
71
240
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
0.3
6.4
14
319
R30.0
ICD-10 Finland
Dysuria
1.5
6.4
193
897
G04BD04
ATC
oxybutynin; oral, transdermal
1.4
6.4
309
1578
ZX001
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy
56.4
6.3
8
*
A04AA55
ATC
palonosetron, combinations; systemic
1.8
6.3
96
368
1860B
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOP MAL TEST (ABD/ING),CA EMBR/TERATOCA/CHORIOCA]
+∞
6.3
7
*
3031
Kela drug reimbursment
Apalutamidi
+∞
6.3
7
*
C61, C795
ICD-10 Finland
NA
+∞
6.3
7
*
R33, C61
ICD-10 Finland
NA
+∞
6.3
7
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
0.5
6.3
40
594
A10AE04
ATC
insulin glargine; parenteral
0.8
6.3
603
5218
G04BX08
ATC
NA
1.8
6.3
103
405
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.4
6.3
305
1560
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
4.0
6.2
24
42
-1
SPAT
NA
1.5
6.2
187
869
5BA08
NOMESCO Finland
NA
2.7
6.2
40
103
SPAT1260
SPAT
Consultation of another employee
1.2
6.2
1200
7274
R86.2
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of other drugs, medicaments and biological substances
12.9
6.2
11
6
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
0.4
6.2
18
361
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
6.2
47
134
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.2
6.1
772
4492
N32.0
ICD-10 Finland
Bladder-neck obstruction
1.7
6.1
112
457
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.5
6.1
229
1114
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.3
6.1
488
2691
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
0.5
6.1
63
807
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
0.7
6.1
251
2413
A04
ICPC
Weakness/tiredness general
1.2
6.1
703
4057
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
0.4
6.1
20
379
TKC50
NOMESCO Finland
Training of urinary bladder
3.8
6.0
25
47
A10BA02
ATC
metformin; oral
0.9
6.0
2447
18905
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
0.2
6.0
7
221
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
1.8
6.0
91
349
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.8
6.0
338
3113
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(36304419) Bacteria [Presence] in Urine
6817
27612
1.87
322.70
3.9
3.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
8038
32092
2.00
307.65
4.1
3.5
e6/l
152.7
122.1
0.50
6839
25158
(40768800) Prostate Pathology biopsy report
4677
1667
23.12
307.65
1.2
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
14927
71874
2.36
307.65
9.9
7.8
u/l
83.5
80.6
4.36
14381
67380
(3031040) Bacteria [#/volume] in Urine by Automated count
13744
58881
2.64
307.65
5.3
4.2
e6/l
569.9
696.0
0.15
283
1103
(3000850) Epithelial cells [#/volume] in Urine
5956
22284
2.00
307.65
3.0
2.8
e6/l
2.6
2.9
1.36
5358
19512
(3017446) Testosterone [Moles/volume] in Serum or Plasma
5207
10338
4.00
307.65
2.2
2.1
nmol/l
7.7
14.8
307.65
4439
9070
(3037467) Urinalysis macro (dipstick) panel - Urine
12993
62737
1.95
307.65
4.7
4.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
7175
29212
1.89
307.65
3.9
3.4
e6/l
0.4
0.5
4.51
5987
22278
(3026008) Bacteria identified in Urine by Culture
6260
23267
2.04
307.65
3.5
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
8401
35243
1.90
307.65
4.6
3.9
e6/l
108.8
103.9
0.12
7034
26548
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12867
58978
2.13
307.65
8.0
3.9
%
15.5
23.9
307.65
8714
29228
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
15929
74214
2.99
307.65
11.9
3.9
ug/l
10.5
2.4
28.29
14018
66307
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
9949
41450
2.07
307.65
4.8
2.8
ug/l
1.1
0.7
47.66
7655
29065
(3026782) Osmolality of Urine
5546
20757
1.97
307.65
3.2
2.9
mosm/kgh2o
602.2
583.8
8.33
4912
17686
(40768804) Tissue Pathology biopsy report
7577
33500
1.71
250.63
2.3
2.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
10461
50693
1.67
242.91
7.7
6.6
umol/l
11.7
13.5
41.72
10042
48224
(3015377) Calcium [Moles/volume] in Serum or Plasma
6795
29414
1.72
239.76
4.5
3.3
mmol/l
2.3
2.3
5.90
6028
25150
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
394
308
8.27
236.40
8.6
1.2
u/l
1533.4
78.9
0.49
132
43
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
9323
44447
1.64
222.97
4.5
4.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
4318
17105
1.77
201.01
3.9
3.2
e6/l
0.6
0.8
4.22
2804
9791
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
9675
48936
1.51
155.59
7.9
7.6
mmol/l
1.2
1.2
6.66
7981
41303
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
4338
18278
1.65
155.54
3.6
3.0
e6/l
0.9
1.0
0.47
2815
10886
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
754
1725
2.85
132.82
2.2
1.7
ug/l
22.9
25.2
0.38
740
1691
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
8842
44821
1.46
131.98
6.8
7.0
mmol/l
1.2
1.2
9.94
7982
40559
(3002256) Pathology report gross observation
3033
12109
1.70
130.40
1.4
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
6462
30977
1.49
126.34
2.7
2.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
1772
6075
1.94
124.82
2.9
3.0
—
—
—
0
0
(4035726)
2118
7812
1.81
118.84
1.3
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
14996
85079
1.52
117.93
20.5
16.7
ml/min/173m2
74.1
75.3
11.07
13216
70824
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
15715
90127
1.55
116.76
19.2
17.9
mg/l
30.7
29.7
2.30
13281
74462
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1788
6286
1.89
116.51
3.6
3.0
e6/l
0.2
0.3
2.60
1764
6204
(3019550) Sodium [Moles/volume] in Serum or Plasma
16495
95710
1.61
115.98
22.7
21.4
mmol/l
139.5
139.6
4.27
16098
93284
(3023103) Potassium [Moles/volume] in Serum or Plasma
16505
95915
1.61
112.97
22.9
21.5
mmol/l
4.0
4.0
3.35
16087
93379
(3013650) Neutrophils [#/volume] in Blood by Automated count
9982
52711
1.41
111.77
9.4
9.1
e9/l
4.4
4.5
6.03
8748
45596
(3041096) Erythrocytes [Presence] in Urine by Automated
4852
22548
1.49
106.61
3.6
3.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
11212
60721
1.41
106.01
4.9
5.6
mmol/l
6.9
7.0
13.21
10671
57419
(3009261) Glucose [Presence] in Urine by Test strip
8524
44133
1.40
103.82
3.9
3.5
estimate
0.0
0.0
1.88
1947
7724
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
187
163
7.34
103.47
9.1
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
16454
96107
1.56
100.69
25.2
20.9
umol/l
92.2
91.7
0.79
16444
96058
(3021601) Nitrite [Presence] in Urine by Test strip
8390
43508
1.39
99.84
5.0
4.6
estimate
0.0
0.0
0.50
2030
8308
(3035350) Ketones [Presence] in Urine by Test strip
8409
43799
1.39
96.18
3.8
3.5
estimate
0.0
0.0
0.33
1993
8038
(40761511) CBC panel - Blood by Automated count
15863
92228
1.50
94.36
19.9
16.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
8972
47374
1.38
93.39
11.3
11.5
inr
1.3
1.4
3.06
2661
12682
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
484
1066
2.93
90.93
2.7
3.9
nmol/l
7.2
9.5
0.51
476
1046
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
6666
33826
1.38
86.35
4.1
3.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
8332
43823
1.36
86.33
5.1
5.4
g/l
34.3
34.4
0.52
7687
40665
(3018418) pH of Serum or Plasma
5692
28194
1.40
84.78
5.1
4.5
ph
7.4
7.4
0.46
1296
5425
(3007461) Platelets [#/volume] in Blood
16674
98623
1.51
81.20
30.0
25.6
e9/l
228.3
228.0
0.19
16286
95405
(3035941) MCH [Entitic mass]
16675
98645
1.51
80.91
29.8
25.4
pg
30.6
30.7
1.10
16437
96749
(3010813) Leukocytes [#/volume] in Blood
16677
98678
1.51
80.53
30.0
25.6
e9/l
6.9
7.1
22.76
16236
95070
(3026361) Erythrocytes [#/volume] in Blood
16675
98667
1.51
80.47
29.9
25.5
e12/l
4.4
4.5
154.36
16220
95009
(3024731) MCV [Entitic volume]
16675
98668
1.51
80.45
29.9
25.5
fl
91.9
91.8
4.16
16439
96764
(3000963) Hemoglobin [Mass/volume] in Blood
16676
98680
1.51
80.35
30.1
25.7
g/l
133.5
137.9
192.90
16428
96767
(3013512) EKG study
6088
30741
1.37
79.57
4.3
4.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
16250
95706
1.47
79.41
12.5
11.2
u/l
26.1
28.3
18.84
15598
91730
(40761536) Microorganisms panel - Urine sediment
1876
7548
1.64
75.19
4.0
4.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
4981
24729
1.37
70.35
4.2
3.9
estimate
0.0
0.0
0.02
1837
7468
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
4868
24110
1.38
69.64
2.7
2.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
3616
17063
1.42
68.44
3.7
3.3
mmol/l
2.5
2.4
4.30
3180
14769
(3023368) Bacteria identified in Blood by Culture
6432
33620
1.32
63.02
4.8
4.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
5173
26434
1.33
58.30
2.2
2.3
mg/l
3.0
3.0
0.29
4337
22377
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
3080
14549
1.41
56.67
4.7
4.2
u/l
250.9
244.1
1.06
2917
13754
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1863
7986
1.53
56.25
4.7
4.3
mmol/l
1.2
1.2
1.03
1635
7020
(3003694) ABO and Rh group [Type] in Blood
4773
24220
1.33
55.99
1.3
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
4510
22766
1.34
54.57
7.6
7.0
—
—
—
0
0
(3019225) pH of Specimen
2202
9860
1.47
53.77
4.9
4.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
526
1561
2.17
53.68
6.1
2.7
u/ml
598.0
1077.9
0.37
512
1534
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
2408
11055
1.44
51.45
3.8
3.8
—
—
—
0
0
(3015736) pH of Urine
6405
34368
1.27
47.73
3.6
3.3
ph
5.8
5.6
1.19
32
33
(3021589) Normoblasts [#/volume] in Blood
7382
40701
1.24
41.93
12.1
10.8
e9/l
0.0
0.0
0.01
6136
33362
(3001122) Ferritin [Mass/volume] in Serum or Plasma
6387
34776
1.25
40.08
2.8
3.0
ug/l
240.9
195.4
9.41
5657
31677
(3021960) Folate [Moles/volume] in Serum or Plasma
4662
24591
1.27
38.02
1.6
1.6
nmol/l
18.5
18.9
1.38
3951
21194
(3009542) Hematocrit [Volume Fraction] of Blood
13257
78204
1.24
38.02
21.6
18.9
%
38.4
39.8
31.93
8029
49867
(3002385) Erythrocyte distribution width [Ratio]
12285
72034
1.22
36.26
25.3
21.3
%
13.9
13.9
0.49
12087
70289
(40761535) Cells panel - Urine sediment
1894
8837
1.40
36.14
3.5
3.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
7988
44879
1.22
36.11
5.5
6.4
%
23.9
25.4
23.87
7350
41565
(3013707) Erythrocyte sedimentation rate by Westergren method
11405
66467
1.22
35.18
3.9
4.1
mm/h
14.9
13.2
16.63
10274
60948
(3019069) Monocytes/100 leukocytes in Blood
7813
44091
1.21
32.57
5.7
6.5
%
9.2
9.2
0.06
7248
41093
(1761482) Bacteria [#/volume] in Urine by Culture
759
3001
1.63
31.92
4.5
3.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
7765
43857
1.21
31.84
5.4
6.2
%
2.9
2.9
0.02
7183
40786
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
14725
88453
1.23
31.24
5.1
5.1
mmol/l
6.1
6.2
12.40
12880
79682
(3044889) 12 lead EKG panel
11475
67271
1.20
31.23
4.4
4.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
6017
33198
1.22
31.21
5.3
6.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
7793
44138
1.20
30.60
5.3
6.1
%
60.2
59.0
13.35
7220
41101
(3022096) Basophils/100 leukocytes in Blood
7531
42700
1.20
28.55
5.4
6.2
%
0.6
0.6
5.21
6972
39771
(3023323) Follitropin [Units/volume] in Serum or Plasma
213
585
2.33
26.27
2.8
1.3
iu/l
14.8
11.6
1.87
179
457
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
7322
41798
1.18
24.39
4.2
4.2
ng/l
57.2
83.5
2.44
6003
33077
(3033658) Prothrombin time (PT) actual/Normal
4683
25734
1.20
23.90
4.3
4.5
%
83.4
80.6
10.91
4601
25193
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
7385
42297
1.17
23.29
2.1
2.1
pmol/l
92.2
90.7
1.95
4230
24614
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
2401
12373
1.26
22.32
4.7
4.9
%
31.7
31.7
0.00
1551
8539
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
6181
34998
1.18
22.07
3.1
3.3
ng/l
2005.3
1832.7
1.37
5330
30684
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
3527
19001
1.22
21.78
1.9
1.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
12963
77820
1.17
21.75
3.8
3.9
mu/l
2.2
2.2
0.21
11207
69406
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
14205
85967
1.18
21.31
6.5
6.9
mmol/mol
40.7
41.4
14.48
12715
78783
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
14929
90740
1.19
21.27
5.3
5.4
mmol/l
2.5
2.5
4.08
13206
82838
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2201
11291
1.27
21.18
3.8
4.3
ug/l
20.0
32.0
1.55
1824
9610
(3019309) Folate [Moles/volume] in Red Blood Cells
3932
21469
1.20
21.04
1.9
1.8
nmol/l
1129.3
1134.2
0.12
2875
16311
(3022621) pH of Urine by Test strip
1240
5936
1.35
19.82
3.0
2.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
14557
88540
1.17
18.90
4.8
4.9
mmol/l
4.3
4.2
14.57
12944
81286
(21494755) Public health laboratory ask at order entry panel
466
4548
0.64
18.83
1.4
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
14419
87720
1.17
18.13
4.7
4.8
mmol/l
1.3
1.3
37.48
12721
79843
(3027945) Reticulocytes/100 erythrocytes in Blood
2742
14653
1.22
18.01
2.5
2.5
%
1.7
1.7
0.23
2383
12902
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
335
1248
1.72
17.78
1.4
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
3288
17901
1.20
17.77
2.6
2.8
umol/l
12.2
12.6
2.25
3011
16604
(3019198) Lymphocytes [#/volume] in Blood
8178
47876
1.15
17.43
5.2
6.0
e9/l
1.7
1.9
16.52
7016
41621
(3000330) Specific gravity of Urine by Test strip
1086
5203
1.34
17.26
4.1
3.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
8233
48314
1.14
16.66
5.3
6.1
e9/l
0.2
0.2
4.19
7046
41910
(3014576) Chloride [Moles/volume] in Serum or Plasma
2880
15603
1.20
16.27
6.8
7.7
mmol/l
104.9
104.6
2.48
2822
15214
(3004789) Transferrin [Mass/volume] in Serum or Plasma
3082
16802
1.20
16.27
2.6
2.8
g/l
2.2
2.2
5.00
2815
15567
(3019150) Specific gravity of Urine by Refractometry
3586
19814
1.18
16.23
4.3
3.9
kg/l
1.0
1.0
0.53
593
2953
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
242
844
1.83
16.08
1.4
1.2
u/l
105.2
57.1
1.62
178
528
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
13994
85196
1.15
15.97
4.2
4.4
mmol/l
1.3
1.3
7.92
12218
77058
(3001604) Monocytes [#/volume] in Blood
7962
46759
1.14
15.54
5.2
5.9
e9/l
0.6
0.7
4.17
6716
39987
(3006315) Basophils [#/volume] in Blood
8005
47072
1.14
15.19
5.2
5.9
e9/l
0.0
0.0
15.46
6768
40322
(3023520) Reticulocytes [#/volume] in Blood
2094
11085
1.22
14.92
2.7
2.6
e9/l
66.1
67.6
1.33
1620
8573
(3022145) Colonoscopy Study observation
2009
10592
1.23
14.89
1.4
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2904
15916
1.19
14.26
2.7
2.8
%
22.7
22.9
0.28
2422
13538
(3012095) Magnesium [Moles/volume] in Serum or Plasma
3229
17870
1.18
14.12
3.2
3.6
mmol/l
0.8
0.8
0.14
3034
16680
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
993
4854
1.31
13.76
2.0
2.0
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
5437
31403
1.14
13.09
2.5
2.7
u/l
58.7
60.6
0.87
4988
29121
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
913
4462
1.31
12.68
1.9
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1329
10342
0.80
12.49
1.7
1.8
%
1.7
1.7
0.11
1096
8715
(3017181) Myelocytes/100 leukocytes in Blood
1652
8692
1.23
12.42
3.1
4.2
%
1.2
0.9
3.50
553
2845
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
3852
21847
1.15
11.97
1.9
1.7
pmol/l
23006641.8
28327590.9
0.28
3047
17898
(3021440) Promyelocytes/100 leukocytes in Blood
1562
8204
1.23
11.94
3.1
4.2
%
0.1
0.1
0.32
520
2640
(3025159) Blasts/100 leukocytes in Blood
1454
7589
1.23
11.80
3.2
4.2
%
0.1
0.2
0.66
439
2212
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1359
7051
1.24
11.65
1.8
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1350
7008
1.24
11.52
7.9
10.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5448
31674
1.13
11.50
2.0
2.1
nmol/l
79.0
75.9
11.81
4641
27794
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
147
489
1.92
11.44
1.9
1.5
u/l
6.9
6.5
0.12
78
227
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
98
279
2.24
11.43
4.9
2.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5153
29902
1.13
11.15
3.6
3.3
u/l
35.6
37.8
0.95
4850
28158
(3002179) Metamyelocytes/100 leukocytes in Blood
1479
7815
1.22
10.65
3.1
4.0
%
1.1
0.6
4.35
389
2050
(40767503) Oxygen content in Capillary blood by calculation
564
2653
1.36
10.21
2.4
2.7
%
15.7
16.4
3.25
317
1450
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
1081
5576
1.24
9.79
2.0
2.0
ug/l
3.1
2.1
0.95
930
4944
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
126
427
1.88
9.37
1.2
1.1
u/l
22.2
34.3
1.33
76
329
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
126
427
1.88
9.37
1.2
1.1
u/l
77.1
102.7
1.98
81
346
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1478
7908
1.20
9.36
3.4
3.9
mmol/l
1.6
1.6
0.09
1050
5771
(3012501) Base excess in Blood by calculation
583
2796
1.33
9.33
4.1
4.8
mmol/l
2.4
2.5
0.24
371
1871
(3013290) Carbon dioxide [Partial pressure] in Blood
583
2797
1.33
9.31
4.1
4.8
kpa
4.9
5.0
0.53
568
2725
(3009343) pH of Capillary blood
1523
8182
1.20
9.23
3.5
3.9
ph
7.4
7.4
0.04
225
1015
(3011397) Hemoglobin [Presence] in Urine by Test strip
3692
21200
1.13
9.22
3.8
3.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1541
8288
1.20
9.22
3.5
3.9
kpa
5.1
5.1
1.24
1411
7652
(3027315) Oxygen [Partial pressure] in Blood
584
2809
1.33
9.17
4.1
4.8
kpa
8.3
8.4
0.21
569
2736
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
45
97
2.95
9.15
3.2
6.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
599
2898
1.32
9.04
3.7
4.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1420
7595
1.20
9.03
1.6
1.7
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
45
98
2.92
9.00
1.6
3.0
—
—
—
0
0
(3010421) pH of Blood
642
3144
1.31
8.89
4.0
4.8
ph
7.4
7.4
0.10
570
2727
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
14
374
0.24
7.87
12.0
12.6
nmol/l
1032.4
803.9
0.72
14
351
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
129
468
1.76
7.80
1.6
1.2
u/l
107.6
110.3
0.07
116
399
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
9355
56718
1.09
7.73
3.2
3.3
u/l
58.7
63.1
3.13
8465
52082
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
297
1318
1.44
7.67
2.0
2.2
mg/l
30.4
28.0
0.23
79
360
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
1029
5423
1.22
7.66
2.6
2.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
124
449
1.76
7.57
1.7
1.2
u/l
38.7
28.9
0.75
110
381
(4034850)
375
3208
0.74
7.49
14.5
12.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
204
843
1.54
7.47
1.8
1.9
u/field
2.1
1.7
0.39
90
341
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
28
495
0.36
7.30
1.2
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
522
2561
1.30
7.21
2.6
3.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
389
3285
0.75
7.14
1.4
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
105
1145
0.58
7.06
1.5
2.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1523
8373
1.17
7.05
3.3
3.0
ml/min/173m2
62.3
61.4
0.37
624
3450
(3027944) Amphetamines [Presence] in Urine
103
1127
0.58
7.02
1.5
2.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
107
1159
0.58
7.01
1.6
2.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
107
1158
0.58
6.99
1.4
2.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
148
579
1.63
6.86
1.7
1.8
u/field
2.3
2.9
0.44
97
411
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
357
3031
0.74
6.82
1.4
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
105
1131
0.59
6.75
1.4
1.2
nmol/l
1.5
1.4
0.62
95
1022
(3028626) Oxygen [Partial pressure] in Capillary blood
589
2966
1.27
6.68
2.7
3.0
kpa
7.8
7.8
0.25
550
2741
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
25
46
3.45
6.56
1.0
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
417
2012
1.32
6.54
2.8
3.8
%
2.1
1.5
2.15
299
1557
(3019832) Treponema pallidum Ab [Presence] in Serum
347
2939
0.75
6.53
1.5
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
1144
6184
1.19
6.51
1.6
1.7
g/l
1.6
1.5
2.66
968
5261
(3016879) Cocaine [Presence] in Urine
102
1091
0.59
6.41
1.5
2.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
41
576
0.45
6.23
5.3
5.8
u/ml
37.6
1466.9
—
7
118
(3007930) Methemoglobin/Hemoglobin.total in Blood
961
5137
1.20
6.22
4.5
5.6
%
0.9
0.9
0.39
887
4835
(3028271) Lactate [Moles/volume] in Capillary blood
398
1924
1.32
6.19
1.8
2.0
mmol/l
1.9
1.8
1.12
389
1873
(3017732) Neutrophils [#/volume] in Blood
1104
6000
1.18
5.92
2.7
3.2
e9/l
4.2
4.3
0.34
792
4337
(3045414) Leukocytes [Presence] in Urine
744
3901
1.22
5.91
2.1
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2305
13199
1.12
5.87
1.8
1.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
316
2661
0.75
5.77
1.6
1.6
iu/ml
18.9
7.5
0.32
77
639
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
933
5020
1.19
5.65
3.8
4.3
mmol/l
24.6
24.6
0.34
849
4614
(3006184) Hemoglobin [Mass/volume] in Capillary blood
552
2818
1.25
5.64
2.2
2.3
g/l
124.9
131.0
5.64
417
2055
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
654
5027
0.82
5.54
1.9
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2665
15436
1.11
5.53
5.8
6.7
mmol/l
1.0
1.0
0.63
2468
14425
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
526
4130
0.80
5.48
1.8
1.7
nmol/l
43.0
44.6
0.86
512
3950
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
131
528
1.58
5.48
3.2
2.9
u/l
206.9
210.6
0.19
131
521
(1001926) Buprenorphine [Presence] in Urine by Screen method
82
887
0.59
5.46
1.5
2.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
84
301
1.78
5.44
1.9
2.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
609
3164
1.23
5.32
3.9
3.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
967
5248
1.18
5.31
4.5
5.5
%
1.6
1.7
2.26
892
4944
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
416
3339
0.79
5.28
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
365
2965
0.78
5.13
1.6
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
9707
59518
1.07
5.02
3.0
3.1
pmol/l
15.0
15.0
1.69
8374
52674
(3014051) Protein [Presence] in Urine by Test strip
396
1973
1.28
5.01
2.5
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
1088
5998
1.16
4.93
3.7
4.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
3155
18534
1.10
4.90
1.9
2.1
s
30.4
30.4
0.12
3062
18006
(3009466) Valproate [Moles/volume] in Serum or Plasma
164
1486
0.70
4.84
3.3
4.5
umol/l
314.5
342.1
1.97
125
1249
(3047181) Lactate [Moles/volume] in Blood
716
3821
1.20
4.80
5.2
6.7
mmol/l
1.3
1.4
1.47
605
3415
(1617658) Protocol used for examination of sentinel lymph nodes
14
21
4.24
4.78
1.1
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2283
13220
1.11
4.75
1.9
1.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
109
437
1.59
4.72
4.3
2.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
68
741
0.58
4.72
2.1
3.8
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
285
2362
0.76
4.72
1.3
1.4
nmol/l
1.0
0.8
2.01
238
1952
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1967
11306
1.12
4.70
2.8
3.0
umol/l
9.3
11.4
3.23
1741
10106
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
305
2499
0.77
4.63
1.7
1.7
mg/l
11.0
11.9
0.92
274
2338
(3039000) Anion gap in Blood
539
2812
1.22
4.59
5.7
7.6
mmol/l
11.1
11.4
1.17
473
2556
(3018572) Chloride [Moles/volume] in Blood
539
2812
1.22
4.59
5.7
7.6
mmol/l
104.9
105.2
0.64
473
2556
(3015235) Bicarbonate [Moles/volume] in Capillary blood
651
3463
1.20
4.54
2.9
3.3
mmol/l
24.3
24.5
0.31
580
3038
(3051387) C reactive protein [Mass/volume] in Capillary blood
445
2277
1.25
4.54
3.5
3.5
mg/l
34.6
31.2
0.94
289
1511
(4211845)
116
477
1.55
4.53
4.1
2.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
896
4905
1.17
4.48
2.8
2.9
u/ml
0.3
0.3
0.42
513
2794
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1830
10513
1.12
4.42
2.8
3.2
ng/l
259.5
266.6
0.19
1671
9670
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1652
11627
0.89
4.39
2.3
2.5
ug/l
6.9
8.4
2.63
1396
10279
(4038314)
12
17
4.48
4.37
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
690
5143
0.85
4.24
4.9
5.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
2958
17443
1.09
4.20
29.6
29.8
inr
1.5
1.5
0.13
455
2307
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
3987
23806
1.08
4.18
1.7
1.7
mmol/l
1.3
1.4
2.60
3134
19578
(3004451) EKG impression Narrative
142
624
1.45
4.09
1.3
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
2331
13617
1.10
4.07
6.8
8.1
%
95.5
95.2
1.24
2210
13141
(3017817) Protein [Mass] in Urine collected for unspecified duration
153
1354
0.72
4.01
2.5
2.4
—
0.7
—
0
12
(3028707) Methadone [Presence] in Urine by Screen method
47
539
0.55
4.00
1.8
3.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
77
297
1.65
3.96
1.1
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
2098
12216
1.10
3.92
7.2
8.7
g/l
120.8
122.8
4.26
2008
11815
(3017354) Segmented neutrophils/100 leukocytes in Blood
256
1248
1.31
3.92
2.7
3.7
%
61.5
59.5
0.54
148
806
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1243
7033
1.13
3.92
8.2
9.7
mmol/l
23.8
24.2
4.55
1169
6486
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
263
2143
0.78
3.89
1.5
1.7
mg/l
3.4
4.5
0.82
196
1521
(3014111) Lactate [Moles/volume] in Serum or Plasma
1899
11008
1.11
3.89
6.5
7.5
mmol/l
1.4
1.4
1.30
1815
10550
(3008757) Leukocyte morphology finding [Identifier] in Blood
277
1367
1.29
3.87
3.2
4.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
287
2311
0.79
3.86
1.3
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
7037
42943
1.06
3.86
2.2
2.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1216
6879
1.13
3.85
1.5
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
52
572
0.58
3.83
2.1
2.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
172
1481
0.74
3.81
1.6
1.7
g/l
1.0
1.0
0.12
133
1118
(3000012) Reticulocyte production index
152
690
1.40
3.71
1.3
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
153
696
1.40
3.69
12.7
10.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
531
3993
0.84
3.68
4.5
4.8
mmol/l
4.0
4.0
0.09
480
3743
(1002224) Polysomnography panel
360
2804
0.81
3.62
1.0
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
208
1727
0.76
3.60
1.4
1.5
u/ml
114.8
115.3
0.02
48
386
(3041354) Potassium [Moles/volume] in Venous blood
320
1625
1.25
3.58
2.6
2.6
mmol/l
4.1
4.1
0.54
314
1612
(3035285) Chloride [Moles/volume] in Venous blood
320
1625
1.25
3.58
2.6
2.6
mmol/l
105.9
105.7
0.17
314
1611
(3000475) Leukocytes [#/volume] in Synovial fluid
354
2755
0.81
3.54
1.6
1.6
e6/l
19154.5
15993.0
0.51
236
2027
(46235355) HIV 1 and 2 tests - Meaningful Use set
1476
10312
0.90
3.46
1.5
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
2525
14913
1.09
3.46
6.6
7.8
mmol/l
0.6
1.0
5.61
1928
11652
(3019977) pH of Arterial blood
163
759
1.37
3.45
2.3
2.5
ph
7.4
7.4
0.34
56
273
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
3208
19135
1.08
3.42
1.6
1.8
mg/l
1.8
1.5
1.97
2521
15117
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
471
3552
0.84
3.40
2.3
2.4
ug/min
120.6
137.1
0.30
254
2156
(3033705) Calcium.ionized [Moles/volume] in Venous blood
314
1602
1.25
3.40
2.7
2.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
3180
18975
1.08
3.35
4.2
4.9
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
107
972
0.70
3.34
1.1
1.1
iu/ml
3.1
1.8
—
8
46
(3024522) Salmonella sp identified in Specimen by Organism specific culture
245
1217
1.28
3.32
1.4
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
33
395
0.53
3.32
5.4
5.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
19
275
0.44
3.32
2.1
2.7
nmol/l
126.4
135.8
0.23
19
239
(3018405) Lactate [Moles/volume] in Arterial blood
638
4679
0.86
3.27
4.1
4.5
mmol/l
1.4
1.4
0.73
621
4588
(3017143) Hepatitis C virus Ab [Presence] in Serum
1199
8444
0.90
3.27
1.6
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
427
2262
1.20
3.24
2.2
1.3
u/l
7.9
7.1
1.09
343
1823
(3045424) Erythrocytes [Presence] in Urine
298
1525
1.24
3.17
1.4
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
527
3909
0.85
3.15
1.6
1.7
u/l
37.7
37.5
0.07
437
3339
(3003888) Timothy IgE Ab [Units/volume] in Serum
72
696
0.66
3.14
1.0
1.1
u/ml
5.9
3.7
0.28
30
324
(3014148) Varicella zoster virus Ab [Titer] in Serum
87
809
0.68
3.12
1.1
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
92
394
1.48
3.11
2.1
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
92
394
1.48
3.11
2.1
2.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1472
10226
0.91
3.10
1.2
1.3
titre
401.5
452.8
0.67
268
2043
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
72
692
0.66
3.06
2.0
2.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
93
850
0.69
3.04
1.2
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
48
504
0.60
3.03
1.0
1.1
u/ml
0.7
2.8
2.80
16
206
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
95
864
0.70
3.03
2.3
2.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
240
1205
1.27
3.02
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
240
1205
1.27
3.02
1.4
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1751
10242
1.09
3.01
2.6
2.6
g/l
65.7
66.3
2.77
1554
9378
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
26
324
0.51
3.01
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
192
1569
0.77
3.01
1.2
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
54
550
0.62
3.00
24.0
30.6
ug/l
113.7
114.2
0.02
46
470
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
36
406
0.56
2.99
1.0
1.0
u/ml
0.3
0.3
0.09
12
107
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
27
330
0.52
2.95
1.1
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
733
4091
1.14
2.94
3.2
3.6
u/ml
1167.3
2095.8
0.58
621
3593
(3010726) Horse dander IgE Ab [Units/volume] in Serum
61
599
0.65
2.89
1.0
1.1
u/ml
1.0
1.5
0.36
15
139
(3023430) Cat dander IgE Ab [Units/volume] in Serum
44
466
0.60
2.89
1.0
1.0
u/ml
0.6
2.6
2.38
15
180
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
247
1252
1.26
2.89
1.4
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
588
3236
1.16
2.88
1.3
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
396
2980
0.84
2.85
1.9
2.6
umol/l
29.6
34.4
5.21
319
2487
(3025468) Yersinia sp identified in Specimen by Organism specific culture
238
1204
1.26
2.84
1.4
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
198
1598
0.78
2.83
1.1
1.1
iu/ml
62.2
189.5
0.58
39
310
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1226
8549
0.90
2.81
1.5
1.6
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
88
799
0.70
2.81
1.1
1.2
titre
78.4
148.7
1.73
19
135
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1257
7265
1.11
2.80
6.0
7.8
mmol/l
24.4
24.6
0.96
1243
7191
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
323
2469
0.83
2.78
1.4
1.4
g/l
1.2
1.2
0.12
308
2343
(3038515) Glucose [Moles/volume] in Venous blood
488
2657
1.17
2.76
3.7
3.7
mmol/l
7.4
7.9
4.33
478
2607
(3015171) Extractable nuclear Ab [Units/volume] in Serum
336
2557
0.83
2.76
1.2
1.2
u/ml
0.2
0.6
2.31
28
243
(40768443) Skin Pathology biopsy report
739
4148
1.14
2.74
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
240
1223
1.25
2.71
1.4
1.5
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
37
401
0.59
2.69
1.3
1.3
%
69.2
62.3
0.70
32
346
(3008037) Lactate [Moles/volume] in Venous blood
510
2796
1.16
2.66
3.7
3.5
mmol/l
1.6
1.7
0.58
500
2736
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
313
2387
0.83
2.65
1.3
1.4
g/l
0.2
0.2
0.77
295
2258
(3024471) HLA-A [Type]
36
391
0.58
2.65
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
35
381
0.58
2.60
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
301
2298
0.83
2.58
1.2
1.2
titre
1136.0
1054.7
—
5
38
(3005322) IgE [Units/volume] in Serum or Plasma
567
4113
0.87
2.58
1.3
1.3
u/ml
480.2
320.3
0.83
522
3806
(3007566) Smooth muscle Ab [Titer] in Serum
307
2338
0.83
2.57
1.2
1.2
titre
122.8
115.0
0.06
29
204
(3004588) Protein electrophoresis panel - Serum or Plasma
1447
8463
1.09
2.54
2.2
2.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
103
893
0.73
2.53
1.1
1.1
—
—
—
0
0
(4062490)
105
907
0.73
2.52
1.3
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
74
677
0.69
2.50
1.0
1.1
u/ml
0.6
1.0
0.50
27
274
(3027801) Oxygen [Partial pressure] in Arterial blood
2498
14937
1.07
2.50
6.7
7.8
kpa
12.0
11.8
2.08
2351
14230
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
90
795
0.72
2.49
1.1
1.1
u/ml
0.4
1.6
3.29
36
333
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2499
14948
1.07
2.47
6.7
7.8
kpa
5.1
5.1
0.25
2347
14252
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
250
1932
0.82
2.46
1.3
1.4
e6/l
36.7
28.7
0.11
181
1523
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
105
485
1.38
2.45
1.8
2.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
80
717
0.71
2.42
1.1
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
129
617
1.33
2.41
1.6
2.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
251
1934
0.82
2.40
1.3
1.4
e6/l
478.3
2648.4
1.23
194
1602
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
67
618
0.69
2.39
2.0
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
146
714
1.30
2.35
3.1
3.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
129
620
1.32
2.35
1.6
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
129
620
1.32
2.35
1.6
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
129
620
1.32
2.35
1.6
2.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
149
733
1.29
2.30
1.4
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
198
1009
1.25
2.30
1.5
1.5
—
—
—
0
0
(3012544) pH of Venous blood
2037
12135
1.07
2.28
4.1
4.2
ph
7.4
7.4
0.09
11
76
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
200
1567
0.81
2.28
1.2
1.2
u/ml
277.8
288.7
0.24
126
992
(3009445) Proteinase 3 Ab [Units/volume] in Serum
700
4966
0.89
2.27
1.5
1.5
u/ml
16.6
16.5
0.01
13
125
(3010144) Erythrocytes [#/volume] in Synovial fluid
142
1157
0.78
2.27
1.4
1.3
e6/l
128519.7
145921.7
0.14
101
809
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
146
718
1.29
2.26
1.4
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
24
78
1.95
2.26
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
780
5498
0.90
2.26
1.3
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
1000
5783
1.10
2.26
4.1
4.4
mmol/l
23.7
23.9
1.12
898
5157
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
36
373
0.61
2.25
3.2
2.8
umol/l
26.4
29.7
1.85
30
284
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
37
139
1.69
2.24
1.0
1.1
umol/l
2.3
2.8
0.69
32
127
(3027135) IgG subclass 1 [Mass/volume] in Serum
107
903
0.75
2.23
1.3
1.4
g/l
7.7
7.1
0.68
69
629
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
103
483
1.36
2.22
1.8
2.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
237
1820
0.82
2.22
1.4
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
107
902
0.75
2.22
1.3
1.4
g/l
3.5
3.1
0.98
71
629
(3024139) IgG subclass 3 [Mass/volume] in Serum
107
902
0.75
2.22
1.3
1.4
g/l
0.5
0.5
0.06
72
629
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
255
1944
0.83
2.21
1.4
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
103
484
1.35
2.20
1.8
2.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
206
1600
0.82
2.17
1.0
1.1
u/ml
4.6
9.4
0.76
15
138
(3000991) Gas panel - Venous blood
1774
10538
1.08
2.16
8.0
9.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
8
4.76
2.15
1.3
1.0
—
—
—
0
0
(4094501)
384
2820
0.86
2.14
1.1
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
39
0.00
2.11
0.0
1.1
—
0.2
—
0
13
(1761868) Lipid panel - Serum or Plasma
4505
27541
1.05
2.11
3.3
3.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
19
230
0.52
2.11
1.8
1.5
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
51
481
0.67
2.09
29.5
33.1
ug/l
7.2
7.2
0.10
43
424
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
67
601
0.71
2.09
1.1
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
120
986
0.77
2.08
1.2
1.2
miu/ml
216.7
168.0
0.47
26
221
(3020682) Albumin/Creatinine [Ratio] in Urine
5740
37600
0.96
2.07
4.0
4.2
mg/mmol
9.5
10.6
0.91
3700
25936
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
32
119
1.71
2.03
1.0
1.1
iu/ml
10.5
19.2
0.67
12
45
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
514
2886
1.13
2.00
1.5
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
755
4336
1.11
1.99
1.3
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
539
3848
0.89
1.99
1.6
1.6
titre
91.5
250.7
4.02
23
156
(3045716) Anion gap in Serum or Plasma
69
610
0.72
1.99
2.1
2.4
mmol/l
9.3
9.0
0.28
55
445
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
144
722
1.27
1.97
1.4
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
73
331
1.40
1.96
7.0
7.1
—
—
—
0
0
(4198724)
16
199
0.51
1.95
1.3
2.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
347
1902
1.16
1.92
1.3
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
76
656
0.73
1.90
2.1
2.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
5496
35975
0.96
1.89
3.1
3.4
mmol/l
8.1
8.4
3.65
4337
29945
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2078
13944
0.94
1.89
1.2
1.2
u/ml
1.8
2.1
0.45
506
3514
(3001019) Free T4 and TSH panel - Serum or Plasma
201
1539
0.83
1.88
1.5
1.4
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
104
503
1.31
1.88
1.5
1.5
%
2.6
4.5
1.30
23
121
(40768446) Kidney Pathology biopsy report
51
469
0.69
1.87
1.7
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
272
1466
1.18
1.86
6.3
12.6
mmol/l
7.3
7.5
0.83
227
1193
(3029634) Reagin Ab [Titer] in Serum by VDRL
151
1188
0.81
1.86
1.9
2.3
titre
3.8
4.3
—
5
35
(3044007) Cell count panel - Peritoneal fluid
40
385
0.66
1.85
1.7
2.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
108
0.41
1.85
2.0
3.9
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
8
17
2.99
1.83
1.4
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
62
277
1.42
1.83
1.4
1.7
nmol/l
4.5
6.0
0.28
56
246
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
16
194
0.52
1.82
2.7
2.9
mg/l
5.8
7.0
0.62
11
156
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
5289
32556
1.04
1.82
2.2
2.3
u/l
235.1
260.5
1.22
4945
30533
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
143
725
1.25
1.81
1.4
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
386
2145
1.15
1.79
1.5
1.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
90
430
1.33
1.79
5.5
5.8
u/ml
36.1
70.3
0.61
30
129
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
125
0.46
1.79
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
183
1405
0.83
1.78
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
493
2786
1.13
1.77
1.5
1.7
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
33
130
1.61
1.74
2.8
2.7
u/field
0.2
0.2
0.10
33
130
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
256
1383
1.18
1.73
1.4
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
5439
35548
0.96
1.72
3.2
3.5
mg/l
341.8
350.7
0.06
3556
24889
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
453
2555
1.13
1.69
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
453
2556
1.13
1.68
1.4
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1483
8845
1.07
1.67
2.4
2.6
u/l
34.1
58.5
1.68
1241
7620
(3027923) C peptide [Moles/volume] in Serum or Plasma
78
655
0.76
1.66
1.2
1.2
nmol/l
1.3
1.2
0.09
63
488
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
166
1276
0.82
1.66
1.1
1.1
—
—
—
0
0
(4010399)
1044
7138
0.92
1.65
1.4
1.4
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
43
183
1.49
1.65
1.6
1.7
ug/l
80.7
111.2
1.42
34
150
(3006270) Folate [Moles/volume] in Blood
164
855
1.22
1.64
1.1
1.2
nmol/l
342.4
319.3
0.69
125
666
(3023487) Leukocytes [#/volume] in Peritoneal fluid
55
486
0.72
1.64
1.5
2.2
e6/l
968.7
4847.2
1.12
42
352
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
232
1251
1.18
1.62
2.4
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
1938
11669
1.06
1.62
4.1
4.2
mmol/l
1.6
1.7
0.77
1539
9396
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
38
158
1.53
1.62
1.5
1.2
u/ml
68.7
129.1
0.76
33
149
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1670
10012
1.06
1.61
2.1
2.4
g/l
0.2
0.2
0.45
1528
9206
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
520
2969
1.12
1.60
1.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
225
1676
0.85
1.59
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
727
5037
0.91
1.59
1.1
1.2
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
15
176
0.54
1.57
2.0
2.4
—
175.8
—
0
26
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
727
4227
1.10
1.57
2.8
3.4
mg/l
68.4
45.5
0.62
564
3441
(3007164) IgA [Mass/volume] in Serum or Plasma
2004
13377
0.95
1.56
1.5
1.5
g/l
2.7
3.0
4.68
1182
8206
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
48
429
0.71
1.55
1.4
2.1
e6/l
31818.8
7603.0
0.82
32
249
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
162
850
1.21
1.54
1.4
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
708
4116
1.10
1.54
2.8
3.4
ratio
3.4
5.6
0.58
59
316
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
178
1346
0.84
1.52
1.1
1.1
g/l
1.5
1.6
0.47
158
1225
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1935
11683
1.06
1.49
4.1
4.1
kpa
5.8
5.8
1.28
1890
11308
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
44
396
0.70
1.49
1.1
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
12
148
0.51
1.49
1.2
1.7
—
69.1
—
0
18
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
313
2260
0.88
1.47
1.5
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
307
1707
1.14
1.47
1.3
1.3
mmol/l
63.1
64.5
0.25
256
1362
(4024509)
143
746
1.22
1.46
1.7
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
197
1469
0.85
1.45
1.1
1.1
—
—
—
0
0
(4212803)
10
129
0.49
1.43
1.1
1.1
—
—
—
0
0
(43055459) Dabigatran [Mass/volume] in Serum or Plasma
14
45
1.98
1.42
1.4
1.5
ug/l
79.0
133.7
—
7
31
(3000492) Spirometry study
1173
7934
0.93
1.42
1.5
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
79
0.40
1.42
1.4
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
1030
6996
0.93
1.41
2.5
2.7
g/l
10.7
11.0
0.79
915
6423
(3028026) IgM [Mass/volume] in Serum or Plasma
807
5532
0.92
1.41
2.0
2.0
g/l
1.3
1.4
0.29
711
5012
(3034860) Kappa light chains.free [Mass/volume] in Serum
724
4235
1.09
1.40
2.8
3.4
mg/l
73.3
63.9
0.44
557
3445
(3026692) Albumin [Mass/volume] in Peritoneal fluid
41
368
0.71
1.39
1.3
1.5
g/l
12.8
13.3
0.17
30
280
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
425
2999
0.90
1.38
1.9
1.9
pmol/l
176.4
199.1
3.50
390
2783
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
105
826
0.81
1.37
1.0
1.0
ng/l
317.1
312.4
0.05
78
562
(3018834) Bilirubin.total [Presence] in Urine by Test strip
12
37
2.06
1.36
4.3
4.3
—
0.0
—
0
8
(4281824)
46
403
0.72
1.35
1.1
1.3
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
14
46
1.93
1.35
1.6
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
366
2600
0.89
1.35
1.7
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
213
1568
0.86
1.35
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
24
237
0.64
1.33
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
233
1701
0.87
1.32
1.4
1.4
—
—
—
0
0
(4306422)
139
1058
0.83
1.32
1.2
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
106
828
0.81
1.31
1.0
1.0
ng/l
717.0
716.0
0.01
75
547
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
106
828
0.81
1.31
1.0
1.0
ng/l
38.8
41.3
0.29
78
551
(3032868) Hemoglobin electrophoresis panel in Blood
5
76
0.42
1.29
1.0
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
289
2075
0.88
1.29
1.2
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
209
1534
0.86
1.29
1.7
1.8
mu/l
268.6
272.1
0.08
200
1434
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
30
280
0.68
1.28
7.6
7.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
213
1560
0.87
1.28
2.1
2.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
162
1212
0.85
1.27
1.9
2.3
ml
740.0
698.1
0.53
91
793
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1164
6963
1.07
1.26
4.0
4.7
ng/l
108.3
109.6
0.14
976
6066
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
64
526
0.77
1.24
1.5
1.4
u/l
8.0
6.6
0.23
53
447
(3037556) Urate [Mass/volume] in Serum or Plasma
49
418
0.74
1.24
1.5
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
124
946
0.83
1.23
1.4
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
28
262
0.68
1.22
1.4
1.3
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
18
67
1.71
1.22
1.1
1.1
u/field
1.2
1.0
0.35
13
43
(40760888) Immunoglobulin light chains.free panel - Serum
550
3204
1.09
1.21
2.6
3.4
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
6
82
0.46
1.20
1.0
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
313
2225
0.89
1.20
1.2
1.3
mg/l
604.0
607.7
0.04
291
2115
(3041918) Cholesterol [Moles/volume] in Pleural fluid
35
313
0.71
1.20
1.5
1.2
mmol/l
1.7
1.4
1.19
22
202
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
357
2037
1.11
1.19
1.4
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
272
1947
0.89
1.18
1.2
1.3
mmol/l
3.8
4.0
1.81
252
1826
(3024263) Appearance of Synovial fluid
82
649
0.80
1.18
1.7
1.5
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
20
78
1.63
1.16
1.1
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
123
651
1.20
1.15
2.6
2.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
135
0.56
1.15
1.1
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1754
11641
0.95
1.15
1.2
1.2
iu/ml
33.6
41.8
1.41
477
3450
(3023410) Appearance of Cerebral spinal fluid
107
821
0.83
1.15
1.4
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
266
1497
1.13
1.13
4.2
4.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
9
105
0.54
1.12
1.4
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
2018
12302
1.05
1.12
6.5
7.6
mmol/l
11.8
11.2
2.02
1894
11616
(3038071) Oxygen [Partial pressure] in Mixed venous blood
40
345
0.74
1.11
7.5
8.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
387
2706
0.91
1.11
1.1
1.1
titre
159.1
208.1
0.37
11
69
(3051101) Glucose [Moles/volume] in Cord blood
27
249
0.69
1.11
5.5
6.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
106
556
1.21
1.10
1.5
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
106
556
1.21
1.10
1.5
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
683
4035
1.08
1.10
2.4
2.6
g/l
1.3
1.1
0.52
560
3439
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1608
10680
0.95
1.10
1.2
1.2
u/ml
10.8
15.0
1.32
500
3798
(44813793)
48
401
0.76
1.08
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
136
732
1.18
1.07
3.6
3.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
40
342
0.74
1.06
1.6
1.9
ug/l
15.4
594.6
1.16
40
322
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
3512
21680
1.03
1.04
4.0
4.2
ng/l
643.6
707.0
0.10
3058
18950
(3045462) Protein/Creatinine [Ratio] in Urine
5
70
0.45
1.04
9.4
3.4
g/mol
9.0
45.9
—
5
62
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
70
0.45
1.04
1.4
1.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
9
29
1.97
1.04
1.8
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
47
225
1.33
1.03
1.1
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
30
267
0.71
1.03
2.5
2.8
mu/l
14.0
26.1
2.80
24
247
(3003129) Base excess in Capillary blood by calculation
70
354
1.26
1.03
1.8
1.7
mmol/l
-0.1
0.1
0.18
65
332
(3020650) Glucose [Presence] in Urine
42
198
1.35
1.02
1.3
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
633
3742
1.08
1.02
1.8
1.8
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
21
199
0.67
1.01
2.6
5.0
u/l
46.8
60.5
—
5
72
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
19
0.00
1.01
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
34
155
1.39
1.01
1.6
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
140
1034
0.86
1.00
1.5
2.0
titre
760.0
3085.3
—
8
53
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
50
243
1.31
1.00
2.2
2.7
mmol/l
6.8
8.4
2.51
36
147
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
22
92
1.52
0.99
3.1
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
119
639
1.18
0.99
1.8
1.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
172
952
1.15
0.98
1.3
1.3
nmol/l
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
152
834
1.16
0.97
1.2
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
128
693
1.17
0.97
1.3
1.2
mmol/l
2.3
2.2
0.43
118
648
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
116
623
1.18
0.97
2.8
3.7
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
109
818
0.85
0.96
1.1
1.2
%
90.9
95.8
1.11
96
758
(3037756) Immunofixation for Serum or Plasma
486
2852
1.08
0.96
1.4
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
200
1121
1.13
0.95
3.8
4.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
79
610
0.82
0.95
1.6
1.6
g/l
0.9
0.9
0.02
79
604
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
194
1087
1.13
0.93
1.4
1.3
nmol/l
0.2
0.3
0.60
21
108
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
797
4768
1.06
0.93
2.1
2.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
16
157
0.65
0.93
1.1
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
744
4442
1.07
0.93
2.1
2.4
g/l
10.2
10.5
1.09
592
3755
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1173
7812
0.95
0.93
1.2
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
797
4771
1.06
0.92
2.1
2.4
g/l
7.4
7.3
0.84
558
3542
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
100
0.57
0.91
1.8
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
794
4756
1.06
0.90
2.1
2.4
g/l
4.0
3.9
0.67
539
3410
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
11
117
0.60
0.90
1.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
11
39
1.79
0.90
1.7
1.8
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
193
1085
1.13
0.89
1.4
1.3
nmol/l
0.7
1.8
0.59
185
1041
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
163
0.66
0.89
5.6
5.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
115
852
0.86
0.89
1.1
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
69
535
0.82
0.88
1.1
1.1
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
13
49
1.68
0.88
1.2
1.4
u/field
1.4
0.9
—
7
24
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
15
59
1.61
0.88
1.2
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
250
1759
0.90
0.87
2.0
2.8
u/ml
639.2
6268.9
0.72
17
128
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
485
2860
1.08
0.87
1.8
2.2
%
90.0
84.4
7.45
460
2723
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
141
1027
0.87
0.87
1.1
1.1
%
108.9
109.2
0.05
119
930
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
73
0.52
0.86
9.0
5.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
164
916
1.14
0.85
1.4
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
463
3163
0.93
0.85
1.3
1.4
iu/ml
7.8
11.2
—
7
62
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
153
1105
0.88
0.84
1.4
1.3
pmol/l
52.2
101.5
1.05
86
331
(3003327) Ova and parasites identified in Stool by Light microscopy
306
2126
0.91
0.84
1.6
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
374
2188
1.09
0.83
1.3
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
32
270
0.75
0.83
1.1
1.8
—
—
—
0
0
(3012565) Volume of 24 hour Urine
104
563
1.17
0.83
2.0
2.4
ml
1945.4
1974.8
0.10
81
486
(3008838) Polymorphonuclear cells/100 leukocytes in Peritoneal fluid
0
16
0.00
0.82
0.0
1.8
—
22.7
—
0
6
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
17
0.00
0.81
0.0
6.0
—
0.4
—
0
17
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
227
1298
1.11
0.81
3.2
3.5
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
20
1.90
0.81
1.0
1.2
%
2.2
3.1
—
6
20
(3036489) Thrombin time
594
3541
1.07
0.81
1.7
2.1
s
22.4
22.1
0.24
531
3212
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
17
71
1.52
0.80
1.3
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
9
32
1.79
0.78
1.3
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
35
288
0.77
0.77
1.6
1.8
%
201.6
188.9
0.36
30
268
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
104
0.61
0.77
1.1
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
333
2293
0.92
0.77
3.9
6.0
iu/ml
3594.3
1300.4
0.31
44
384
(3032057) Clostridioides difficile [Presence] in Stool
46
232
1.26
0.75
1.7
2.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
116
640
1.15
0.75
1.3
1.3
titre
95.6
70.8
—
9
52
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
317
2184
0.92
0.75
1.5
1.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
30
143
1.33
0.73
2.1
2.1
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
17
155
0.70
0.72
1.1
1.4
%
75.5
71.2
1.23
17
145
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
17
155
0.70
0.72
1.1
1.4
mu/l
326.6
1747.3
1.17
17
145
(3033799) Differential panel - Peritoneal fluid
55
425
0.82
0.72
1.4
2.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
36
291
0.79
0.71
1.0
1.1
u/ml
—
6.9
—
0
22
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
30
144
1.32
0.70
2.2
2.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
435
2582
1.07
0.70
2.0
2.5
%
208.1
206.8
0.10
410
2456
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
150
847
1.13
0.70
1.1
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
245
1421
1.10
0.70
1.6
1.5
%
64.7
63.5
0.18
151
948
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
26
219
0.75
0.69
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
2048
12633
1.03
0.69
1.3
1.3
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
20
90
1.41
0.68
1.1
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
98
716
0.87
0.68
2.1
2.3
ug/min
64.4
146.0
1.34
31
173
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
12
48
1.59
0.68
2.8
3.2
pmol/l
178.3
26.8
—
7
30
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1345
8237
1.04
0.68
8.5
9.8
%
0.6
0.7
9.56
1332
8176
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
607
3649
1.06
0.67
2.2
2.4
g/l
36.6
37.2
1.56
499
3158
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
441
2983
0.94
0.66
1.1
1.1
iu/ml
107.4
97.5
0.23
136
927
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
694
4632
0.95
0.66
2.4
2.4
ug/l
607.8
627.2
0.06
672
4423
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
38
302
0.80
0.66
2.6
2.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
291
1707
1.08
0.66
1.4
1.6
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
135
962
0.89
0.65
1.5
1.8
mg/l
4.1
4.4
0.51
123
916
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
143
810
1.12
0.65
1.6
1.6
u/ml
31.1
28.7
0.19
31
185
(3026470) Cobalt [Mass/volume] in Blood
157
895
1.11
0.64
1.9
1.9
ug/l
4.0
3.5
0.25
132
785
(3025577) Chromium [Mass/volume] in Blood
153
871
1.12
0.64
2.0
2.0
ug/l
2.1
1.9
0.18
124
714
(3020491) Glucose [Moles/volume] in Blood
131
739
1.13
0.64
1.6
2.1
mmol/l
7.4
7.4
0.01
89
510
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
360
2134
1.07
0.63
2.3
1.2
u/l
42.2
38.8
0.18
307
1849
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1201
7355
1.04
0.62
2.4
2.6
nmol/l
368.5
372.5
0.24
1117
6795
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
98
710
0.88
0.62
1.1
1.2
mmol/l
11.0
12.3
0.93
27
276
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
29
236
0.78
0.62
1.3
1.3
g/l
0.3
0.3
0.52
20
188
(3015350) Toxocara sp Ab [Presence] in Serum
0
14
0.00
0.62
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
9
91
0.63
0.62
1.0
1.0
—
—
—
0
0
(4268621)
99
716
0.88
0.61
2.3
2.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
78
426
1.16
0.61
2.8
2.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
92
668
0.87
0.61
1.0
1.1
mg/l
283.6
277.4
0.44
84
608
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
481
3233
0.94
0.61
1.4
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
107
769
0.88
0.61
1.0
1.1
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
15
0.00
0.61
0.0
1.1
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
15
0.00
0.61
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
67
498
0.85
0.60
2.4
2.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
113
809
0.89
0.60
1.1
1.1
au/ml
52.5
56.9
—
5
15
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
127
0.70
0.60
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
26
126
1.31
0.59
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
290
1710
1.08
0.59
1.5
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
731
4435
1.05
0.59
2.2
2.4
g/l
3.2
3.0
2.43
546
3479
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
53
401
0.84
0.59
7.8
8.3
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
13
119
0.69
0.59
1.6
1.3
ml/s/173m2
0.6
1.0
—
8
77
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
58
435
0.85
0.59
2.4
2.3
umol/l
53.3
57.0
0.52
44
361
(3045788) Cell count panel - Pleural fluid
255
1497
1.08
0.59
1.6
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
423
2530
1.06
0.58
2.7
3.4
u/ml
232.1
1113.3
2.54
376
2316
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
6
22
1.73
0.58
2.2
1.1
nmol/l
988.2
480.1
—
6
22
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
124
880
0.89
0.58
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
107
766
0.89
0.58
1.3
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
119
673
1.12
0.58
4.6
4.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
23
110
1.33
0.58
1.4
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
23
110
1.33
0.58
1.4
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
23
110
1.33
0.58
1.4
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
19
162
0.74
0.58
1.4
2.4
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
16
140
0.73
0.57
1.1
1.2
nmol/l
393755.2
155842.8
0.24
16
120
(44806420)
54
406
0.84
0.57
2.5
2.3
—